{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:24:29Z","timestamp":1793499869456,"version":"4.5.0"},"reference-count":41,"publisher":"BMJ","issue":"1","funder":[{"name":"Foundation of the state Baden-W\u00fcrttemberg","award":["D.3830"],"award-info":[{"award-number":["D.3830"]}]},{"name":"EU Joint Programme-Neurodegenerative Diseases networks Genfi-Prox","award":["01ED2008A"],"award-info":[{"award-number":["01ED2008A"]}]},{"name":"EU (Moodmarker) program","award":["01EW2008"],"award-info":[{"award-number":["01EW2008"]}]},{"name":"Boehringer Ingelheim Ulm University BioCenter","award":["D.5009"],"award-info":[{"award-number":["D.5009"]}]},{"DOI":"10.13039\/100009281","name":"Fondation Thierry Latran","doi-asserted-by":"publisher","award":["D.2468"],"award-info":[{"award-number":["D.2468"]}],"id":[{"id":"10.13039\/100009281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Federal Ministry of Education and Research","award":["FTLDc 01GI1007A"],"award-info":[{"award-number":["FTLDc 01GI1007A"]}],"id":[{"id":"https:\/\/ror.org\/04pz7b180","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1279"],"award-info":[{"award-number":["SFB1279"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALS association","award":["D.5809"],"award-info":[{"award-number":["D.5809"]}],"id":[{"id":"https:\/\/ror.org\/00mwp5989","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Elevated levels of neurofilament light (NfL) and heavy (NfH) chain in amyotrophic lateral sclerosis (ALS) cerebrospinal fluid (CSF) and serum reflect neuro-axonal degeneration and are used as diagnostic biomarkers. However, studies comparing the differential diagnostic potential for ALS of all four parameters are missing. Here, we measured serum NfL\/NfH and CSF NfL\/NfH in a large cohort of ALS and other neurological disorders and analysed the differential diagnostic potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In total CSF and serum of 294 patients were analysed. The diagnostic groups comprised: ALS (n=75), frontotemporal lobar degeneration (FTLD) (n=33), Alzheimer\u2019s disease (n=20), Parkinson\u2019s disease (dementia) (n=18), Creutzfeldt-Jakob disease (n=11), non-neurodegenerative controls (n=77) (Con) and 60 patients who were seen under the direct differential diagnosis of a patient with ALS (Con.DD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CSF and serum NfL and NfH showed significantly increased levels in ALS (p&lt;0.0001) compared with Con and Con.DD. The difference between ALS and FTLD was markedly stronger for NfH than for NfL. CSF and serum NfL demonstrated a stronger correlation (r=0.84 (95% CI 0.80 to 0.87), p&lt;0.001) than CSF and serum NfH (r=0.68 (95% CI 0.61 to 0.75), p&lt;0.0001). Comparing ALS and Con.DD, receiver operating characteristic analysis revealed the best area under the curve (AUC) value for CSF NfL (AUC=0.94, 95%\u2009CI 0.91 to 0.98), followed by CSF NfH (0.93, 95% CI 0.88 to 0.98), serum NfL (0.93, 95% CI 0.89 to 0.97) and serum NfH (0.88, 95% CI 0.82 to 0.94).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results demonstrate that CSF NfL and NfH as well as serum NfL are equally suited for the differential diagnosis of ALS, whereas serum NfH appears to be slightly less potent.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2021-327129","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T13:57:01Z","timestamp":1629467821000},"page":"68-74","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":91,"title":["Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS"],"prefix":"10.1136","volume":"93","author":[{"given":"Steffen","family":"Halbgebauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6697-6522","authenticated-orcid":false,"given":"Petra","family":"Steinacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3977-6995","authenticated-orcid":false,"given":"Federico","family":"Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Weishaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7652-7023","authenticated-orcid":false,"given":"Patrick","family":"Oeckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"von Arnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Dorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Feneberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-0338","authenticated-orcid":false,"given":"Angela","family":"Rosenbohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Silani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C","family":"Ludolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6647-5944","authenticated-orcid":false,"given":"Markus","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"2024021904150828000_93.1.68.1","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-020-00406-3","article-title":"Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers","volume":"15","author":"Zucchi","year":"2020","journal-title":"Mol Neurodegener"},{"key":"2024021904150828000_93.1.68.2","article-title":"Diagnostic and prognostic performance of neurofilaments in ALS","volume":"9","author":"Poesen","year":"2018","journal-title":"Front Neurol"},{"key":"2024021904150828000_93.1.68.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0058-z"},{"key":"2024021904150828000_93.1.68.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2013.221"},{"key":"2024021904150828000_93.1.68.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31287-4"},{"key":"2024021904150828000_93.1.68.6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00415-017-8413-3","article-title":"Epidemiology of amyotrophic lateral sclerosis in southern Germany","volume":"264","author":"Rosenbohm","year":"2017","journal-title":"J Neurol"},{"key":"2024021904150828000_93.1.68.7","first-page":"730","article-title":"The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer's disease, frontotemporal dementia, and amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"11","author":"Forgrave","year":"2019","journal-title":"Alzheimers Dement"},{"key":"2024021904150828000_93.1.68.8","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1212\/WNL.0000000000004761","article-title":"Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis","volume":"90","author":"Feneberg","year":"2018","journal-title":"Neurology"},{"key":"2024021904150828000_93.1.68.9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-318704"},{"key":"2024021904150828000_93.1.68.10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/21678421.2016.1241279","article-title":"Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: data from the German MND-net","volume":"18","author":"Steinacker","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2024021904150828000_93.1.68.11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-311387"},{"key":"2024021904150828000_93.1.68.12","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","article-title":"Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS","volume":"95","author":"Benatar","year":"2020","journal-title":"Neurology"},{"key":"2024021904150828000_93.1.68.13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323372"},{"key":"2024021904150828000_93.1.68.14","doi-asserted-by":"publisher","DOI":"10.1080\/146608200300079536"},{"key":"2024021904150828000_93.1.68.15","doi-asserted-by":"publisher","DOI":"10.2165\/11640070-000000000-00000"},{"key":"2024021904150828000_93.1.68.16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr179"},{"key":"2024021904150828000_93.1.68.17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821103e6"},{"key":"2024021904150828000_93.1.68.18","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26987"},{"key":"2024021904150828000_93.1.68.19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31827f0fd1"},{"key":"2024021904150828000_93.1.68.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70090-0"},{"key":"2024021904150828000_93.1.68.21","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.3.181"},{"key":"2024021904150828000_93.1.68.22","unstructured":"Brown P , Brunk C , Budka H . WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease. World Health organization, communicable disease surveillance and response, 2003."},{"key":"2024021904150828000_93.1.68.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(99)00210-5"},{"key":"2024021904150828000_93.1.68.24","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24273"},{"key":"2024021904150828000_93.1.68.25","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/acn3.51355","article-title":"Comparison of Simoa TM and Ella TM to assess serum neurofilament-light chain in multiple sclerosis","volume":"8","author":"Gauthier","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"2024021904150828000_93.1.68.26","doi-asserted-by":"crossref","first-page":"e1390","DOI":"10.1212\/WNL.0000000000006318","article-title":"Serum neurofilament light chain in behavioral variant frontotemporal dementia","volume":"91","author":"Steinacker","year":"2018","journal-title":"Neurology"},{"key":"2024021904150828000_93.1.68.27","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-312972"},{"key":"2024021904150828000_93.1.68.28","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1515\/cclm-2019-0015","article-title":"Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches","volume":"57","author":"Wilke","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"2024021904150828000_93.1.68.29","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24980"},{"key":"2024021904150828000_93.1.68.30","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.0000000000003688","article-title":"Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias","volume":"88","author":"Steinacker","year":"2017","journal-title":"Neurology"},{"key":"2024021904150828000_93.1.68.31","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","article-title":"Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia","volume":"87","author":"Rohrer","year":"2016","journal-title":"Neurology"},{"key":"2024021904150828000_93.1.68.32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-80370-6","article-title":"Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS","volume":"11","author":"Brodovitch","year":"2021","journal-title":"Sci Rep"},{"key":"2024021904150828000_93.1.68.33","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25276"},{"key":"2024021904150828000_93.1.68.34","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316605"},{"key":"2024021904150828000_93.1.68.35","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22948","article-title":"Neurofilament levels in patients with neurological diseases: a comparison of neurofilament light and heavy chain levels","volume":"33","author":"Ku\u0161nierov\u00e1","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"2024021904150828000_93.1.68.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14612-6"},{"key":"2024021904150828000_93.1.68.37","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s43587-021-00028-4","article-title":"A neuronal blood marker is associated with mortality in old age","volume":"1","author":"Kaeser","year":"2021","journal-title":"Nat Aging"},{"key":"2024021904150828000_93.1.68.38","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1007\/s00415-020-09838-9","article-title":"Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease","volume":"267","author":"Falzone","year":"2020","journal-title":"J Neurol"},{"key":"2024021904150828000_93.1.68.39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/nan.12511","article-title":"Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with amyotrophic lateral sclerosis","volume":"45","author":"Gille","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2024021904150828000_93.1.68.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.05.062"},{"key":"2024021904150828000_93.1.68.41","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004029"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2021-327129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T07:18:30Z","timestamp":1708327110000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2021-327129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,14]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/jnnp-2021-327129"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2021-327129","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]}}}